It can be a fair proposition to ask a fully developed nation to invest more into pharmaceutical research.
Making the drugs once they are tested is the cheap part. Ensuring the drugs do what they are supposed to and don’t cause long term effects is extremely expensive.
The US spends about half of global spending on drug research, out spending all of Europe per
Can also ask why most of the Europe pharmaceutical companies charge US citizen more for medication than their own people. It’s really ALL pharmaceutical companies charge US more. Regarding BioNTech, it is innovative but don’t have the manufacturing and distribution capacity as Pfizer. Can’t really said Pfizer is pure evil (just based on this context). [distribute the medication
Well it's probably not the government wanting, but the pharma lobby. What's flabbergasting for the rest of the world is, that the US citizens keep voting for people who indulge big companies instead of people who negotiate the best prices vor them.With Trump they promoted the goat to be the head gardener. A tendency we see in Germany too, to be honest, with our Black Rock chancellor.
Actually that’s not true. It is the US government wanting.
Read the history on how Pharma pricing and US gov policies evolve after WW2. Can also find some reputable research on how Europe gov set limitation on their own companies pricing. It may change your perspective. I remember one of EU gov basically set policies to their own local pharma to charge certain discount compare to the US price to ensure affordability. Basically asking their own pharma comp to overcharge US citizen and subsidize their own.
I gained my source from “the economist” regarding the fight between Pharma companies and the gov since Joe Biden trying to make medication in US more affordable, and how Donald Trump continue to double down the fight. It also shows the arguments that both sides are using to “justify” their policies. It shows the perspectives on all stalk-holders. For example, when US Gov forces pharma to drop their price in US, the R&D spending are first to cut, that’s including EU pharmaceutical companies as well. We are not talking about 1 individual company, but aggregate R&D spending.
Long story short, US citizen are subsidizing the whole world since WW2. All financial modeling are based on US citizen. The rest of the market is just icing, hence pharma companies can charge so little for the original brand to others, especially to the 3rd world countries. It was justified and done purposefully by US gov because US was a superpower that the no. 2 can’t even come near close. However, it has become the standard practice for ALL pharmaceutical companies worldwide to do so. There is a long histories on how the policies slow evolved etc. It is quite interesting. I am not even from US.
•
u/bshjbdkkdnd 4h ago
It can be a fair proposition to ask a fully developed nation to invest more into pharmaceutical research.
Making the drugs once they are tested is the cheap part. Ensuring the drugs do what they are supposed to and don’t cause long term effects is extremely expensive.
The US spends about half of global spending on drug research, out spending all of Europe per
https://efpia.eu/publications/data-center/the-pharma-industry-in-figures-rd/pharmaceutical-rd-expenditure-in-europe-usa-china-and-japan/